Precision Therapeutics, Forged by Evolution
Cutting-edge research aimed at new generation oral peptides for high value targets
Our Approach
Building Upon Nature to Improve Human Health
Kissaki Biosciences is using novel approaches to advance new oral peptide-based therapeutics. Our focus is on high value, validated targets in immunology and inflammation (I&I), with a particular interest in gastrointestinal disorders, such as inflammatory bowel disease (IBD).
Our Pipeline
Meet the Kissaki Team
Our team capitalizes on decades of peptide engineering and drug development expertise to accelerate our treatments into and through the clinic. In addition to our Founders, we have assembled a stellar group of highly accomplished SMEs and clinical KOLs.
About us
The Story & Purpose
Behind Our Name
Gorō Nyūdō Masamune was a medieval Japanese blacksmith
widely acclaimed as Japan’s greatest swordsmith.
In keeping with this tradition of excellence and innovation, we
chose the name Kissaki, which in Japanese, means the “tip of the
sword” or “cutting edge”. The hunt for cutting edge technologies
to treat human diseases is the core of our mission.
Innovation
Our Technology
We engineer disease targeting miniature proteins, leveraging AI modeling, and proven natural and unnatural scaffolds for potent, orally bioavailable therapeutics.
Inflammatory
Bowel Disease
Ulcerative Colitis (UC) and Crohn’s Disease (CD) are the major forms of Inflammatory Bowel Disease (IBD). Despite the large number of FDA and EMA-approved therapeutics, the unmet medical need remains high, and new therapeutics are needed.
Get in Touch With Us
Fill out this form to contact Kissaki Biosciences